Message from the Director

The Charles C. Gates Regenerative Medicine and Stem Cell Biology Program was established on August 23, 2006 as the result of a generous gift from the Gates Frontiers Fund. Our comprehensive program is open to all investigators within the CU system who are interested in stem cell research. The goal of our program is to understand the biology of stem cells in order to develop new therapies for debilitating diseases such as cancer, pediatric diseases, heart diseases, juvenile diabetes, vascular diseases, liver diseases, blood diseases, and neuronal diseases.

Our Program is housed in the recently-opened Research Complex I on the Anschutz Medical Campus, the largest new biomedical and clinical campus in the United States.

Dennis Roop,
Director

Chris Hogan,
Associate Director

In the News

Plan to establish a Core facility that will generate mouse and human "induced pluripotent stem" (iPS) cells
The purpose of this message is to find out whether there is sufficient interest within the faculty to support this Core. If you are interested in using Core-provided iPS cells (human or mouse) , please fill out the short survey.

Researchers find safer way to transform skin cells into stem cells
In a paper released this week in the online version of Stem Cells, University of Colorado Denver’s School of Medicine researchers Wenbo Zhou, PhD, and Curt Freed, MD, have created “human induced pluripotent stem cells” (iPS cells)—reprogrammed to look and act like embryonic stem cells—from human skin fibroblasts using a common cold virus. ...more >

Scientists celebrate reversal of policy
Stem-cell researcher Dr. Dennis Roop was teaching a class on bioethics Monday morning when he glanced at his watch — the next 15 minutes, he told his medical students, would revitalize science. ...more >

Stem Cell Research — KWGN News
KWGN2 News interviewed Stem-cell researcher Dr. Dennis Roop after the announcement of the reversal of the stem cell research policy. -March 10, 2009 ...more >